West Family Investments’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Buy |
36,207
+2,739
| +8% | +$42.3K | 0.15% | 143 |
|
|
2025
Q1 | $498K | Hold |
33,468
| – | – | 0.19% | 109 |
|
|
2024
Q4 | $443K | Buy |
33,468
+15,638
| +88% | +$207K | 0.15% | 136 |
|
|
2024
Q3 | $254K | Buy |
+17,830
| New | +$254K | 0.09% | 235 |
|
|
2022
Q4 | – | Sell |
-21,318
| Closed | -$276K | – | 261 |
|
|
2022
Q3 | $276K | Buy |
21,318
+1,886
| +10% | +$24.4K | 0.11% | 165 |
|
|
2022
Q2 | $273K | Buy |
19,432
+2,234
| +13% | +$31.4K | 0.11% | 176 |
|
|
2022
Q1 | $246K | Sell |
17,198
-24,114
| -58% | -$345K | 0.07% | 226 |
|
|
2021
Q4 | $563K | Buy |
41,312
+14,670
| +55% | +$200K | 0.15% | 104 |
|
|
2021
Q3 | $436K | Sell |
26,642
-30,820
| -54% | -$504K | 0.11% | 157 |
|
|
2021
Q2 | $967K | Buy |
+57,462
| New | +$967K | 0.26% | 56 |
|